
泰锟医药
泰锟医药
Biotech/Healthcare
Taikun Pharma provides clinical trial drug management services that meet international standards. It operates GDP/GMP-compliant clinical supply centers in Shanghai, China; New Jersey, United States; and Melbourne, Australia.
Latest round: Series B (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.